Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message.

AIMS The sources of prescribing information are legion but there is little knowledge about which are actually used in practice by doctors when prescribing. The aims of this study were to determine the sources of prescribing information considered important by doctors, establish which were used in practice, and investigate if hospital and primary care physicians differed in their use of the sources. METHODS Two hundred general practitioners (GPs) and 230 hospital doctors were asked to rate information sources in terms of their importance for prescribing 'old' and 'new' drugs, and then to name the source from which information about the last new drug prescribed was actually derived. RESULTS Among 108 GPs, the Drugs and Therapeutics Bulletin and medical journal articles were most frequently rated as important for information on both old and new drugs while pharmaceutical representatives and hospital/consultant recommendations were more important for information on new drugs, as opposed to old. In practice, information on the last new drug prescribed was derived from pharmaceutical representatives in 42% of cases and hospital/consultant recommendations in 36%, with other sources used infrequently. Among 118 hospital doctors, the British National Formulary (BNF) and senior colleagues were of greatest theoretical importance. In practice, information on the last new drug prescribed was derived from a broad range of sources: colleagues, 29%; pharmaceutical representatives, 18%; hospital clinical meetings, 15%; journal articles, 13%; lectures, 10%. GPs and hospital doctors differed significantly in their use of pharmaceutical representatives (42% vs 18%) and colleagues (7% vs 29%) as sources of prescribing information (P < 0.0001 for both). CONCLUSIONS The sources most frequently rated important in theory were not those most used in practice, especially among GPs. Both groups under-estimated the importance of pharmaceutical representatives. Most importantly, the sources of greatest practical importance were those involving the transfer of information through the medium of personal contact.

[1]  R Jones,et al.  A study of general practitioners' reasons for changing their prescribing behaviour , 1996, BMJ.

[2]  A. Deehan,et al.  Surveying general practitioners: does a low response rate matter? , 1997, The British journal of general practice : the journal of the Royal College of General Practitioners.

[3]  D. Bjornson,et al.  Treatment of Medicaid Patients with Asthma: Comparison with Treatment Guidelines Using Disease-Based Drug Utilization Review Methodology , 1998, The Annals of pharmacotherapy.

[4]  H. Hogerzeil,et al.  Promoting rational prescribing: an international perspective. , 1995, British journal of clinical pharmacology.

[5]  L. Finelli,et al.  Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995. , 1998, Chest.

[6]  E. Kaner,et al.  General practice postal surveys: a questionnaire too far? , 1996, BMJ.

[7]  M. Angell The pharmaceutical industry--to whom is it accountable? , 2000, The New England journal of medicine.

[8]  E. Rogers Diffusion of Innovations , 1962 .

[9]  Stephen B. Soumerai,et al.  Improving Drug-Therapy Decisions through Educational Outreach , 1983 .

[10]  A. Tylee,et al.  The Treatment of Depression: Prescribing Patterns of Antidepressants in Primary Care in the UK , 1996, British Journal of Psychiatry.

[11]  Jakki J. Mohr,et al.  Communication Strategies in Marketing Channels: A Theoretical Perspective , 1990 .

[12]  R Hartley,et al.  Scientific versus commercial sources of influence on the prescribing behavior of physicians. , 1982, The American journal of medicine.

[13]  M. Feely,et al.  The influence of an academic representative on prescribing by general practitioners. , 1992, British journal of clinical pharmacology.

[14]  S B Soumerai,et al.  Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.

[15]  E. R. Peay,et al.  The role of commercial sources in the adoption of a new drug. , 1988, Social science & medicine.

[16]  J F Steiner,et al.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.

[17]  W. Strauss,et al.  Use of a tiered review for evaluation of appropriate use of hydroxymethylglutaryl coenzyme A reductase-inhibitor therapy. , 1999, Clinical therapeutics.